Radiopharm Theranostics (RADX) Assets Average (2025)
Radiopharm Theranostics (RADX) has disclosed Assets Average for 1 consecutive years, with $79.3 million as the latest value for Q2 2025.
- On a quarterly basis, Assets Average changed N/A to $79.3 million in Q2 2025 year-over-year; TTM through Jun 2025 was $79.3 million, a N/A change, with the full-year FY2025 number at $79.3 million, changed N/A from a year prior.
- Assets Average was $79.3 million for Q2 2025 at Radiopharm Theranostics.
- In the past five years, Assets Average ranged from a high of $79.3 million in Q2 2025 to a low of $79.3 million in Q2 2025.